JD Supra21h
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
New ‘natural’ GLP-1 booster that can be added to any food for weight loss to hit shelves within the next year
NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...
Concerns over Ozempic misuse and eating disorder risks prompt calls for increased screening
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
6 common weight loss myths busted: Expert explains the reasoning behind popular claims
Many are in the chase of quick fixes in weight loss, but more than often it's ineffective. Expert debunks 6 common weight loss myths.
AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
Mirage News17h
RACGP Urges PBS to Subsidise Effective Obesity Drugs
Effective obesity-management medication should be subsidised on the Pharmaceutical Benefits Scheme (PBS) to reduce health inequity, the Royal ...
Mirage News5h
RACGP Urges PBS to Fund Obesity Drugs
Effective obesity-management medication should be subsidised on the Pharmaceutical Benefits Scheme (PBS) to reduce health inequity, the Royal ...
Evoke Pharma, Inc. (EVOK) Q4 2024 Earnings Call Transcript
Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...
The Ozempic workout? How gyms and trainers are catering to a new group of exercisers
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...